Barclays’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2
Closed 4417
2021
Q3
$0 Sell
2
-28
-93% -$74 ﹤0.01% 4862
2021
Q2
$0 Hold
30
﹤0.01% 4956
2021
Q1
$0 Hold
30
﹤0.01% 4933
2020
Q4
$0 Hold
30
﹤0.01% 5030
2020
Q3
$0 Sell
30
-700
-96% -$3.22K ﹤0.01% 5367
2020
Q2
$3K Buy
730
+630
+630% +$4.09K ﹤0.01% 5423
2020
Q1
$0 Sell
100
-49,900
-100% -$185K ﹤0.01% 6281
2019
Q4
$198K Hold
50,000
﹤0.01% 5032
2019
Q3
$124K Sell
50,000
-50,000
-50% -$145K ﹤0.01% 5322
2019
Q2
$316K Buy
+100,000
New +$3.16M ﹤0.01% 4730
2018
Q3
Sell
-400
Closed -$13K 7240
2018
Q2
$13K Sell
400
-4,600
-92% -$159K ﹤0.01% 6408
2018
Q1
$144K Buy
+5,000
New +$132K ﹤0.01% 5109

Other funds holding IFRX

Barclays's IFRX Position: Q4 2021 in Review

Barclays sold out of InflaRx (IFRX) in Q4 2021, closing a stake of 2 shares.

Barclays first reported a position in IFRX in Q1 2018 and held it in 12 quarters. The position peaked at $316K in Q2 2019. 38 funds tracked by Wall St. Rank hold IFRX as of Q4 2021.

  • Barclays reported no remaining InflaRx position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 2 InflaRx shares in Q4 2021.
  • Barclays first reported a position in InflaRx in Q1 2018 and held it in 12 quarters.
  • Barclays's InflaRx position peaked at $316K in Q2 2019.
  • 38 funds tracked by Wall St. Rank held InflaRx as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.